Literature DB >> 9328677

In vitro susceptibility of Staphylococcus aureus including MRSA to four disinfectants.

J Suzuki1, H Komatsuzawa, K Kozai, N Nagasaka.   

Abstract

The spread of nosocomial infections caused by pathogenic organisms such as methicillin-resistant S. aureus (MRSA) has prompted the dental community to focus more attention on certain control strategies. In the present study, we tested the abilities of the four skin disinfectants (povidone iodine, benzalkonium chloride, chlorhexidine gluconate, and ethanol) to prevent horizontal transmission of MRSA in the dental office. The bactericidal activities of the disinfectants were evaluated by the decrement over time of viable cell numbers of four clinical isolated strains of S. aureus: two MRSA strains and two methicillin-sensitive S. aureus (MSSA) strains. The most effective disinfectant was 70 percent ethanol, which eradicated both MRSA and MSSA in less than three minutes. The 0.1 percent chlorhexidine gluconate proved the least effective of four disinfectants. More than 10(2) bacteria survived despite exposure to it for thirty minutes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9328677

Source DB:  PubMed          Journal:  ASDC J Dent Child        ISSN: 1945-1954


  3 in total

Review 1.  Preventing infection from reusable medical equipment: a systematic review.

Authors:  Will Sopwith; Tony Hart; Paul Garner
Journal:  BMC Infect Dis       Date:  2002-03-27       Impact factor: 3.090

2.  Isoenzymatic genotyping of Staphylococcus aureus from dairy cattle and human clinical environments reveal evolutionary divergences.

Authors:  Marcelo Fabiano Gomes Boriollo; Rodrigo Carlos Bassi; José Francisco Höfling
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-09-17       Impact factor: 1.846

3.  Dynamics of the seasonal airborne propagation of Staphylococcus aureus in academic dental clinics.

Authors:  Wagner Luiz de Carvalho Bernardo; Jeferson Júnior da Silva; José Francisco Höfling; Edvaldo Antônio Ribeiro Rosa; Marcelo Fabiano Gomes Boriollo
Journal:  J Appl Oral Sci       Date:  2018-04-05       Impact factor: 2.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.